title: The tenofovir pre-exposure prophylaxis trial in Thailand: researchers should show more openness in their engagement with the community.
authors.forename: Arlene
authors.initials: A
authors.lastname: Chua
authors.forename: Nathan
authors.initials: N
authors.lastname: Ford
authors.forename: David
authors.initials: D
authors.lastname: Wilson
authors.forename: Paul
authors.initials: P
authors.lastname: Cawthorne
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D019058:Community Networks; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006806:Human Rights; D006801:Humans; D018671:Needle-Exchange Programs; D063065:Organophosphonates / Q000627:therapeutic use*; D010344:Patient Advocacy; D012107:Research Design; D019966:Substance-Related Disorders / Q000150:complications; D000068698:Tenofovir; D013785:Thailand
chemical_list: D019380:Anti-HIV Agents; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine